This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Michael Bassler - Innovator in Microfluidic Technology
Introduction
Michael Bassler is a notable inventor based in Mainz, Germany. He has made significant contributions to the field of microfluidics, particularly in the development of devices that enhance the separation of blood serum from samples. His innovative approach has the potential to improve medical diagnostics and treatment processes.
Latest Patents
Michael Bassler holds a patent for a microfluidic device and method for separating off blood serum. This device features a microfluidic structure with a supply duct, a clotting region, and a discharge duct. The design allows for the introduction of a blood sample at a higher pressure, while a lower pressure is applied at the discharge port. This unique configuration facilitates the efficient separation of blood serum, making it a valuable tool in medical applications.
Career Highlights
Throughout his career, Michael Bassler has worked with prestigious organizations, including the Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e. V. His experience in research and development has enabled him to push the boundaries of microfluidic technology. His work has garnered attention for its practical applications in healthcare.
Collaborations
Michael has collaborated with notable colleagues such as Tobias Schunck and Peter Spang. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Michael Bassler's contributions to microfluidic technology exemplify the impact of innovative thinking in the medical field. His patented device for blood serum separation represents a significant advancement that could enhance diagnostic capabilities.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
